| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Dyne Therapeutics Inc (NASDAQ: DYN)
DYN Technical Analysis
4
| As on 9th Jun 2023 DYN STOCK Price closed @ 12.96 and we RECOMMEND Buy for LONG-TERM with Stoploss of 9.50 & Strong Buy for SHORT-TERM with Stoploss of 8.97 we also expect STOCK to react on Following IMPORTANT LEVELS. |
DYNSTOCK Price
| Open | 13.51 | Change | Price | % |
| High | 13.68 | 1 Day | -0.50 | -3.71 |
| Low | 12.89 | 1 Week | -0.07 | -0.54 |
| Close | 12.96 | 1 Month | 2.81 | 27.68 |
| Volume | 451952 | 1 Year | 0.56 | 4.52 |
| 52 Week High 15.17 | 52 Week Low 4.36 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| DYN Daily Charts |
DYN Intraday Charts |
Whats New @ Bazaartrend |
DYN Free Analysis |
|
|
DYN Important Levels Intraday
| RESISTANCE | 14.48 |
| RESISTANCE | 13.99 |
| RESISTANCE | 13.69 |
| RESISTANCE | 13.39 |
| SUPPORT | 12.53 |
| SUPPORT | 12.23 |
| SUPPORT | 11.93 |
| SUPPORT | 11.44 |
DYN Forecast May 2024
| 4th UP Forecast | 22.77 |
| 3rd UP Forecast | 19.62 |
| 2nd UP Forecast | 17.68 |
| 1st UP Forecast | 15.73 |
| 1st DOWN Forecast | 10.19 |
| 2nd DOWN Forecast | 8.24 |
| 3rd DOWN Forecast | 6.3 |
| 4th DOWN Forecast | 3.15 |
DYN Weekly Forecast
| 4th UP Forecast | 15.56 |
| 3rd UP Forecast | 14.73 |
| 2nd UP Forecast | 14.21 |
| 1st UP Forecast | 13.70 |
| 1st DOWN Forecast | 12.22 |
| 2nd DOWN Forecast | 11.71 |
| 3rd DOWN Forecast | 11.19 |
| 4th DOWN Forecast | 10.36 |
DYN Forecast2024
| 4th UP Forecast | 34.79 |
| 3rd UP Forecast | 27.79 |
| 2nd UP Forecast | 23.46 |
| 1st UP Forecast | 19.13 |
| 1st DOWN Forecast | 6.79 |
| 2nd DOWN Forecast | 2.46 |
| 3rd DOWN Forecast | -1.87 |
| 4th DOWN Forecast | -8.87 |
Dyne Therapeutics Inc ( NASDAQ USA Symbol : DYN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
DYN Business Profile
Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. The company was founded in 2017 and is headquartered in Waltham, Massachusetts. Address: 830 Winter Street, Waltham, MA, United States, 02451
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service